Emma Clayton, CEO, Grey Bear Consultancy, talks about the journey to starting her own agency, pharma communications in the COVID-19 era, and empowering women to succeed in the workplace.

Pierre van Weperen, Chief Commercial Officer, Grow Biotech, discusses the potential of medicinal cannabis and big pharma vs start-ups.

Dr William Soliman, Chairman and CEO, Accreditation Council for Medical Affairs, discusses establishing industry benchmarks, what it is like to join the field now, and what it means to be a futurist in medical affairs.

GOLD sits down with Claire Gillis, International CEO, WPP Health Practice, who discusses WPP’s work with the ABC Global Alliance, how communications teams can transform patient outcomes, and the proudest moments from her career so far.

GOLD sits down with Claudia Martinez, Research Programme Manager, Access to Medicine Foundation, who explains the methodology behind the Access to Medicine Foundation’s 2021 Index, why access to medicine is still a challenge for the pharmaceutical industry and how companies can adapt their processes to reach to most vulnerable patient populations.

GOLD is joined in the studio by Arpita Pani, Senior Commercial Governance, Digital and E-Commerce Lead at Ferring Pharmaceuticals, to discuss the evolution and future of digital marketing in pharma, including the industry’s use of social media.

GOLD discusses digital health with Julien De Salaberry, an expert in health tech, who has worked across the pharma and start-up sectors, striving to solve healthcare pain points with technological innovation.

Professor Jonathan Sackier discusses COVID-19 myths and why pharma needs to find alternative ways to share research.